Mode
Text Size
Log in / Sign up
N/A Completed N=59 Randomized Triple-blind Treatment

Changes in Subjects With Posterior Capsule Tightness

Source: ClinicalTrials.gov NCT02353442 ↗
Enrolled (actual)
59
Serious AEs
0.0%
Results posted
Feb 2017
Primary outcomePrimary: Scapular Kinematics at 4weeks (Pre and Post Treatment) — 34.58; 36.00; 34.76; 35.72 degrees

Summary

To identify biomechanical and sensibility changes in people with posterior capsule tightness in people with and without shoulder pain.

Outcome Measures

OutcomeResultp-value
PRIMARY
Scapular Kinematics at 4weeks (Pre and Post Treatment)
34.58; 36.00; 34.76; 35.72; -18.12; -16.47
PRIMARY
Humeral Translations at 4weeks (Pre and Post Treatment).
1.22; 0.85; 0.68; 0.96; 1.38; 1.21
SECONDARY
Strength of the Shoulder External Rotators at 4weeks (Pre and Post Treatment).
89.08; 90.96; 88.98; 94.71
SECONDARY
Pressure Pain Threshold at 4weeks (Pre and Post Treatment).
287.40; 312.12; 351.47; 355.82; 351.33; 409.46
SECONDARY
Pain and Function at 4weeks (Pre and Post Treatment)
46.01; 45.26; 27.10; 17.22

Eligibility Criteria

Inclusion Criteria: all subjects should have posterior capsule tightness and shoulder pain. So they should have:

  • low flexion test (flexion + internal rotation) > 7°, between arms;
  • symptoms consistent to shoulder impingement and arm elevation close to 150° as determined by digital inclinometer. The diagnosis for SIS was made based on a clinical examination and self-reported history. To be classified as having shoulder impingement, subjects had to present with at least 3 of the following: positive Neer test, positive Hawkins test, positive Jobe test, pain with passive or isometric resisted shoulder lateral rotation, pain with active shoulder elevation, and pain in the anterolateral shoulder region.

Exclusion Criteria: Individuals from both groups were excluded if they:

  • were pregnant;
  • had ligamentous laxity based on positive Sulcus test, Apprehension test or anterior drawer;
  • had history of clavicle, scapula or humerus fracture;
  • history of shoulder surgery or traumatic lesion; -had adhesive capsulitis or scoliosis; - had systemic illnesses;
  • transpore tape allergy;
  • body mass index > 28kg/m2;
  • physical therapy treatment in the last 6 months;
  • bilateral symptoms;
  • steroid injection in the last 6 weeks;
  • drugs with muscle relaxant in the last 72 hours.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02353442). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search